Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1966 1
1967 4
1968 2
1969 3
1970 8
1971 5
1972 7
1973 9
1974 6
1975 13
1976 4
1977 10
1978 8
1979 12
1980 13
1981 3
1982 9
1983 14
1984 23
1985 18
1986 14
1987 21
1988 27
1989 22
1990 24
1991 17
1992 23
1993 17
1994 29
1995 26
1996 28
1997 30
1998 37
1999 43
2000 37
2001 41
2002 35
2003 43
2004 58
2005 49
2006 63
2007 66
2008 56
2009 64
2010 70
2011 79
2012 71
2013 96
2014 81
2015 90
2016 88
2017 90
2018 93
2019 83
2020 144
2021 140
2022 158
2023 101
2024 39

Text availability

Article attribute

Article type

Publication date

Search Results

2,199 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Hypogonadotropic hypogonadism 4 with or without anosmia"
Page 1
Testosterone Treatment and Fractures in Men with Hypogonadism.
Snyder PJ, Bauer DC, Ellenberg SS, Cauley JA, Buhr KA, Bhasin S, Miller MG, Khan NS, Li X, Nissen SE. Snyder PJ, et al. N Engl J Med. 2024 Jan 18;390(3):203-211. doi: 10.1056/NEJMoa2308836. N Engl J Med. 2024. PMID: 38231621 Clinical Trial.
METHODS: In a subtrial of a double-blind, randomized, placebo-controlled trial that assessed the cardiovascular safety of testosterone treatment in middle-aged and older men with hypogonadism, we examined the risk of clinical fracture in a time-to-even …
METHODS: In a subtrial of a double-blind, randomized, placebo-controlled trial that assessed the cardiovascular safety of test …
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline.
Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM; Task Force, Endocrine Society. Bhasin S, et al. J Clin Endocrinol Metab. 2010 Jun;95(6):2536-59. doi: 10.1210/jc.2009-2354. J Clin Endocrinol Metab. 2010. PMID: 20525905 Review.
PARTICIPANTS: The Task Force was composed of a chair, selected by the Clinical Guidelines Subcommittee of The Endocrine Society, five additional experts, a methodologist, and a medical writer. ...We recommend against starting testosterone therapy in patients with breast or …
PARTICIPANTS: The Task Force was composed of a chair, selected by the Clinical Guidelines Subcommittee of The Endocrine Society, five …
Use of platelet-rich plasma for COVID-19-related olfactory loss: a randomized controlled trial.
Yan CH, Jang SS, Lin HC, Ma Y, Khanwalkar AR, Thai A, Patel ZM. Yan CH, et al. Int Forum Allergy Rhinol. 2023 Jun;13(6):989-997. doi: 10.1002/alr.23116. Epub 2022 Dec 21. Int Forum Allergy Rhinol. 2023. PMID: 36507615 Free PMC article. Clinical Trial.
INTRODUCTION: The current study evaluated the use of platelet-rich plasma (PRP), an autologous blood product with supraphysiologic concentrations of growth factors, in the treatment of prolonged coronavirus disease 2019 (COVID-19)-related smell loss. METHODS: This multi-instituti …
INTRODUCTION: The current study evaluated the use of platelet-rich plasma (PRP), an autologous blood product with supraphysiologic concentra …
Testosterone Replacement Options.
McCullough AR, Khan M. McCullough AR, et al. Urol Clin North Am. 2022 Nov;49(4):679-693. doi: 10.1016/j.ucl.2022.07.010. Urol Clin North Am. 2022. PMID: 36309423 Review.
The treatment of male hypogonadism is complicated by the multitude of treatments available, the lack of a clear understanding of the differences between treatment modalities, barriers to treatment, and patient misperceptions, unrealistic expectations, and anxieties. This a …
The treatment of male hypogonadism is complicated by the multitude of treatments available, the lack of a clear understanding of the …
Subclinical male hypogonadism.
Corona G, Rastrelli G, Dicuio M, Concetti S, Minnetti M, Pivonello R, Isidori A, Sforza A, Maggi M. Corona G, et al. Minerva Endocrinol (Torino). 2021 Sep;46(3):252-261. doi: 10.23736/S2724-6507.20.03208-3. Epub 2020 Sep 24. Minerva Endocrinol (Torino). 2021. PMID: 32969626
INTRODUCTION: The concept of subclinical or compensated male hypogonadism (SHG), characterized by increased gonadotropins and normal testosterone levels is emerging. ...Whereas the former can be the consequence of several congenital or acquired diseases, also possible caus …
INTRODUCTION: The concept of subclinical or compensated male hypogonadism (SHG), characterized by increased gonadotropins and normal …
Hypopituitarism.
Ascoli P, Cavagnini F. Ascoli P, et al. Pituitary. 2006;9(4):335-42. doi: 10.1007/s11102-006-0416-5. Pituitary. 2006. PMID: 17077946 Review.
Prolactin deficiency is also very rare and generally occurs after global failure of pituitary function. Prolactin deficiency prevents lactation. Hypogonadotropic hypogonadism in males is characterized by low testosterone with low or normal LH and FSH serum concentra …
Prolactin deficiency is also very rare and generally occurs after global failure of pituitary function. Prolactin deficiency prevents lactat …
Endocrinopathies and cancer cachexia.
Dev R, Del Fabbro E, Dalal S. Dev R, et al. Curr Opin Support Palliat Care. 2019 Dec;13(4):286-291. doi: 10.1097/SPC.0000000000000464. Curr Opin Support Palliat Care. 2019. PMID: 31567482 Review.
The following review will highlight the contribution and potential therapeutic interventions for insulin resistance, alterations in ghrelin signaling, and hypogonadism in cancer patients. RECENT FINDINGS: In addition to decreased caloric intake, chronic inflammation, and a …
The following review will highlight the contribution and potential therapeutic interventions for insulin resistance, alterations in ghrelin …
Current Management and Controversies Surrounding Andropause.
Mian AH, Yang DY, Kohler TS. Mian AH, et al. Urol Clin North Am. 2022 Nov;49(4):583-592. doi: 10.1016/j.ucl.2022.07.003. Epub 2022 Oct 7. Urol Clin North Am. 2022. PMID: 36309415 Review.
Andropause is a condition surrounded by controversies, whether it be through its diagnosis or management. As we learn more about the pathophysiology of hypogonadism, our perspectives on the risks and benefits of testosterone therapy have shifted. ...Throughout this review, …
Andropause is a condition surrounded by controversies, whether it be through its diagnosis or management. As we learn more about the pathoph …
Management of hypogonadism from birth to adolescence.
Howard SR, Dunkel L. Howard SR, et al. Best Pract Res Clin Endocrinol Metab. 2018 Aug;32(4):355-372. doi: 10.1016/j.beem.2018.05.011. Epub 2018 Jun 6. Best Pract Res Clin Endocrinol Metab. 2018. PMID: 30086863 Review.
Management of patients with hypogonadism is dependent on the underlying cause. Whilst functional hypogonadism presenting as delayed puberty in adolescence is relatively common, permanent hypogonadism presenting in infancy or adolescence is unusual. The main d …
Management of patients with hypogonadism is dependent on the underlying cause. Whilst functional hypogonadism presenting as de …
Pharmacological management of late-onset hypogonadism.
Rastrelli G, Maggi M, Corona G. Rastrelli G, et al. Expert Rev Clin Pharmacol. 2018 Apr;11(4):439-458. doi: 10.1080/17512433.2018.1445969. Epub 2018 Mar 5. Expert Rev Clin Pharmacol. 2018. PMID: 29505313 Review.
The frequency of late-onset hypogonadism (LOH) ranges between 2 and 15%. Up to 85% of LOH is due to a functional impairment of the hypothalamus-pituitary-testicular axis, mostly secondary to metabolic conditions. Areas covered: This paper provides a comprehensive review of …
The frequency of late-onset hypogonadism (LOH) ranges between 2 and 15%. Up to 85% of LOH is due to a functional impairment of the hy …
2,199 results